Format

Send to

Choose Destination
Epilepsy Res. 2002 Sep;51(1-2):73-80.

Conantokin-L, a new NMDA receptor antagonist: determinants for anticonvulsant potency.

Author information

1
Department of Biology, University of Utah, 257 South 1400 East #201, Salt Lake City, UT 84112-0840, USA.

Abstract

Conantokins are N-methyl-D-aspartate receptor antagonist peptides found in the venoms of marine cone snails. Current intense interest in this peptide family stems from the discovery of their therapeutic potential as anticonvulsants. It was recently reported that conantokin-R is a highly potent anticonvulsant compound, with a protective index of 17.5 when tested in the audiogenic mouse model of epilepsy. Conantokin-L was characterized from Conus lynceus and found to have extensive homology with conantokin-R, except For the C-terminal amino acids. Although conantokin-L appears almost as potent as conantokin-R in standard in vivo assays for conantokins and NMDA receptor binding assays, it is far less potent as an anticonvulsant, with a protective index of 1.2 in the audiogenic mouse model. The results suggest that the C-terminal sequences of conantokin-R and conantokin-L are a major determinant of their anticonvulsant potency.

PMID:
12350383
DOI:
10.1016/s0920-1211(02)00101-8
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center